What the FDA labels say about taking them together
Albuterol and atomoxetine
Atomoxetine's FDA label of May 25, 2026 names albuterol in its drug interactions section; the albuterol labels PlainMeds reads (4) do not name atomoxetine. The atomoxetine label: “Albuterol or Other Beta2 Agonists Prevention or Management Increase the frequency of monitoring blood pressure and heart rate and adjust STRATTERA dosage as clinically appropriate.”
Check it at the source: the albuterol FDA label on DailyMed (effective April 30, 2026, Ritedose Pharmaceuticals, LLC); the atomoxetine FDA label on DailyMed (effective May 25, 2026, Camber Pharmaceuticals, Inc.).
What does the albuterol label say about atomoxetine?
Albuterol's label (effective April 30, 2026) and its 3 other brand-application labels do not name atomoxetine in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Albuterol Sulfate Inhalation Solution), Ritedose Pharmaceuticals, LLC, effective April 30, 2026 (SPL set d4c532be-1f41-60d3-e053-2995a90a98be), via openFDA; the full label on DailyMed
What does the atomoxetine label say about albuterol?
Atomoxetine label, drug interactionsAlbuterol (or other beta 2 agonists) - Action of albuterol on cardiovascular system can be potentiated.
Strattera label (Eli Lilly and Company, June 30, 2026), drug interactionsAlbuterol or Other Beta2 Agonists Prevention or Management Increase the frequency of monitoring blood pressure and heart rate and adjust STRATTERA dosage as clinically appropriate.
Atomoxetine Hydrochloride label (Advagen Pharma Ltd., April 3, 2026), drug interactionsMechanism and Clinical Effect (s); Systemically administered albuterol (e.g., oral) can be potentiated by atomoxetine oral solution, resulting in increases in heart rate and blood pressure [see ].
Source: FDA drug label (Strattera, NDA021411), Eli Lilly and Company, effective June 30, 2026 (SPL set 309de576-c318-404a-bc15-660c2b1876fb), via openFDA
Source: FDA drug label (Atomoxetine Hydrochloride, NDA220320), Advagen Pharma Ltd., effective April 3, 2026 (SPL set 16096e9c-2dcd-4c84-a1a8-1c85d6d6898c), via openFDA
Source: FDA drug label (Atomoxetine), ANDA202682 (Hetero Labs Ltd V), as published by Camber Pharmaceuticals, Inc., effective May 25, 2026 (SPL set f266ab7b-5a68-42b5-b204-e3249bea0aed), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Albuterol | Atomoxetine | |
|---|---|---|
| Labeled for | Asthma | ADHD |
| Boxed warning | No | Yes |
| Pharmacy cost (NADAC) | $0.288 per tablet 2 mg tablet | $0.442 per capsule 40 mg capsule |
| Shortage now | Resolved | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once